TrialThe lancet. Diabetes & endocrinology2021

Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Stephen E Gitelman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.